These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 10586065)

  • 1. Staphylococcal enterotoxin H displays unique MHC class II-binding properties.
    Nilsson H; Björk P; Dohlsten M; Antonsson P
    J Immunol; 1999 Dec; 163(12):6686-93. PubMed ID: 10586065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The crystal structure of staphylococcal enterotoxin H: implications for binding properties to MHC class II and TcR molecules.
    Hâkansson M; Petersson K; Nilsson H; Forsberg G; Björk P; Antonsson P; Svensson LA
    J Mol Biol; 2000 Sep; 302(3):527-37. PubMed ID: 10986116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staphylococcal enterotoxin D is a promiscuous superantigen offering multiple modes of interactions with the MHC class II receptors.
    Al-Daccak R; Mehindate K; Damdoumi F; Etongué-Mayer P; Nilsson H; Antonsson P; Sundström M; Dohlsten M; Sékaly RP; Mourad W
    J Immunol; 1998 Jan; 160(1):225-32. PubMed ID: 9551975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analysis of the binding of staphylococcal enterotoxin D to the T cell receptor Vbeta chain and major histocompatibility complex class II.
    Li Y; Zhu X; Huang Y; Xiong H
    Immunol Lett; 2006 May; 105(1):55-60. PubMed ID: 16481046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-linking of MHC class II molecules by staphylococcal enterotoxin A is essential for antigen-presenting cell and T cell activation.
    Tiedemann RE; Fraser JD
    J Immunol; 1996 Nov; 157(9):3958-66. PubMed ID: 8892628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the MHC class II binding domains of staphylococcal enterotoxin A differentially affect T cell receptor Vbeta specificity.
    Newton DW; Dohlsten M; Olsson C; Segrén S; Lundin KE; Lando PA; Kalland T; Kotb M
    J Immunol; 1996 Nov; 157(9):3988-94. PubMed ID: 8892632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of binding domains on the superantigen, toxic shock syndrome-1, for class II MHC molecules.
    Soos JM; Russell JK; Jarpe MA; Pontzer CH; Johnson HM
    Biochem Biophys Res Commun; 1993 Mar; 191(3):1211-7. PubMed ID: 8466498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of natural variants of staphylococcal superantigens SEG and SEI to TCR and MHC class II molecule.
    Fernández MM; De Marzi MC; Berguer P; Burzyn D; Langley RJ; Piazzon I; Mariuzza RA; Malchiodi EL
    Mol Immunol; 2006 Mar; 43(7):927-38. PubMed ID: 16023209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural dichotomy of staphylococcal enterotoxin C superantigens leading to MHC class II-independent activation of T lymphocytes.
    Lamphear JG; Bohach GA; Rich RR
    J Immunol; 1998 Mar; 160(5):2107-14. PubMed ID: 9498747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enterotoxin residues determining T-cell receptor V beta binding specificity.
    Irwin MJ; Hudson KR; Fraser JD; Gascoigne NR
    Nature; 1992 Oct; 359(6398):841-3. PubMed ID: 1436060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superantigen natural affinity maturation revealed by the crystal structure of staphylococcal enterotoxin G and its binding to T-cell receptor Vbeta8.2.
    Fernández MM; Bhattacharya S; De Marzi MC; Brown PH; Kerzic M; Schuck P; Mariuzza RA; Malchiodi EL
    Proteins; 2007 Jul; 68(1):389-402. PubMed ID: 17427250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of microbial superantigen staphylococcal enterotoxin B at 1.5 A resolution: implications for superantigen recognition by MHC class II molecules and T-cell receptors.
    Papageorgiou AC; Tranter HS; Acharya KR
    J Mol Biol; 1998 Mar; 277(1):61-79. PubMed ID: 9514739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification from a phage display library of peptides that bind to toxic shock syndrome toxin-1 and that inhibit its binding to major histocompatibility complex (MHC) class II molecules.
    Sato A; Ida N; Fukuyama M; Miwa K; Kazami J; Nakamura H
    Biochemistry; 1996 Aug; 35(32):10441-7. PubMed ID: 8756700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Definition of sites on HLA-DR1 involved in the T cell response to staphylococcal enterotoxins E and C2.
    Hargreaves RE; Brehm RD; Tranter H; Warrens AN; Lombardi G; Lechler RI
    Eur J Immunol; 1995 Dec; 25(12):3437-44. PubMed ID: 8566035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staphylococcal toxins bind to different sites on HLA-DR.
    Chintagumpala MM; Mollick JA; Rich RR
    J Immunol; 1991 Dec; 147(11):3876-81. PubMed ID: 1940373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple binding sites on the superantigen, staphylococcal enterotoxin B, imparts versatility in binding to MHC class II molecules.
    Soos JM; Johnson HM
    Biochem Biophys Res Commun; 1994 Jun; 201(2):596-602. PubMed ID: 8002991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of staphylococcal enterotoxin A to purified murine MHC class II molecules in supported lipid bilayers.
    Lee JM; Watts TH
    J Immunol; 1990 Nov; 145(10):3360-6. PubMed ID: 2230121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-targeted superantigens induce lysis of major histocompatibility complex class II-negative T-cell leukemia lines.
    Ihle J; Holzer U; Krull F; Dohlsten M; Kalland T; Niethammer D; Dannecker GE
    Cancer Res; 1995 Feb; 55(3):623-8. PubMed ID: 7530598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial and retroviral superantigens share a common binding region on class II MHC antigens.
    Torres BA; Griggs ND; Johnson HM
    Nature; 1993 Jul; 364(6433):152-4. PubMed ID: 8391645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residues near the amino and carboxyl termini of staphylococcal enterotoxin E independently mediate TCR V beta-specific interactions.
    Lamphear JG; Mollick JA; Reda KB; Rich RR
    J Immunol; 1996 Mar; 156(6):2178-85. PubMed ID: 8690907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.